Sign inJoin waitlistJoin the waitlist

Kenneth Cusi

Professor of Medicine · University of Florida College of Medicine

Credentials: · · · ·

History

University of Florida College of Medicine
Present

Endocrinology, Diabetes, and Metabolism
1992–1994
Baylor University
1989–1992
Faculty of Medical Sciences, University of Buenos Aires
1980–1984

Research

The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases
Hepatology · 2018 · 5,460 citations
The diagnosis and management of non-alcoholic fatty liver disease: practice Guideline by the American Association for the Study of Liver Diseases, American College of…
Hepatology · 2012 · 2,732 citations
A multisociety Delphi consensus statement on new fatty liver disease nomenclature
Review · Journal of Hepatology · 2023 · 2,696 citations

Fernando Bril
63 papers
ML
Mayra Lomonaco
34 papers · 2 as a fellow
ZY
Zobair Younossi
33 papers
Ralph DeFronzo
27 papers
SH
Stephen Harrison
26 papers
Arun Sanyal
23 papers
Diana Barb
22 papers
Rohit Loomba
18 papers
Mary Rinella
17 papers
Fasiha Kanwal
16 papers
Alina Allen
13 papers
SK
Sangeeta Kashyap
12 papers

Grants

Role of Screening and Early Intervention in Primary Care with Low-Dose Pioglitazone for Patients with T2DM and NASH
National Institute of Diabetes and Digestive and Kidney Diseases · R01
Contact PI · $2.3M · University of Florida
2020–2026
u-01 Consortium for the Study of Chronic Pancreatitis,diabetes and Pancreatic Cancer Clinical Centers
National Institute of Diabetes and Digestive and Kidney Diseases · U01
PI · $4.6M · University of Florida
2015–2025
NAFLD in T2DM: Prevalence in Hispanics and Role of Treatment
Department of Veterans Affairs · I01
Contact PI · Veterans Health Administration
2009–2016
General Clinical Research Center
National Center for Research Resources · M01
Project lead · $1M · University of Texas Hlth Science Center
2004–2008

Clinical trials

Low-Dose Pioglitazone in Patients With NASH (AIM 2)
Principal investigator · Recruiting · Phase 2
University of Florida
2020–2027
Lanifibranor in Patients With Type 2 Diabetes & Nonalcoholic Fatty Liver Disease
Principal investigator · Completed · Phase 2
University of Florida
2018–2023
Prevalence of Non-alcoholic Fatty Liver Disease (NAFLD) in Hispanics With Diabetes Mellitus Type 2 (T2DM) and Role of Treatment
Principal investigator · Completed · Phase 4
VA Office of Research and Development
2010–2016
University of Texas H.S.C. San Antonio Pioglitazone in Non-Alcoholic Steatohepatitis Trial (UTHSCSA NASH Trial)
Principal investigator · Completed · Phase 4
University of Florida
2008–2014